Postmenopausal Osteoporosis
📧 Sign up to get email alerts when something new happens for Postmenopausal Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS safety_alert · 2013-11-19Clinical Trial Update: Angeliq Regulatory Post Marketing Surveillance
Bayer's Angeliq post-marketing surveillance update summarizes ongoing regulatory safety monitoring in postmenopausal women, including osteop…